Tonix Pharmaceuticals drug TNX-102 SL gets FDA ok for US Department of Defense funded trial

Tonix Pharmaceuticals CEO Dr. Seth Lederman joined Steve Darling from Proactive to share significant news regarding the company's latest development: the clearance of the Investigational New Drug...

Related Keywords

United States ,Seth Lederman ,Us Department Of Defense ,Drug Administration For The Phase ,Tonix Pharmaceuticals ,Investigational New Drug ,Drug Administration ,North Carolina Institute ,Trauma Recovery ,Markets ,